Minerva Neurosciences, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Burlington, MA
NERV chart
What traders are saying about $NERV
Latest postsMinerva Neurosciences, Inc. news
- Weekly Recap: Warrant-driven Q3 net income and Phase 3 C19 trial launch
TradingView ·
- Minerva Neurosciences, Inc reports results for the quarter ended September 30 - Earnings Summary
TradingView ·
- Minerva Neurosciences Stock Price Forecast. Should You Buy NERV?
StockInvest.us ·
- Minerva Neurosciences (NERV) Tops Q3 EPS by 2c
StreetInsider ·
- Minerva Neurosciences 3Q 2026: EPS ($0.19) — 10-Q Summary
TradingView ·
- Minerva Neurosciences reports Q3 2026 results; ...
Pluang ·
- Form 8K Minerva Neurosciences Inc For: 6 November By Investing.com
Investing.com Canada ·
- Minerva Neurosciences posts Q3 profit on non-cash warrant gain
TradingView ·
- Minerva Neurosciences Reports Q3 2026 Results, $100.7M Net Income
TradingView ·
- Minerva Neurosciences: Q3 Earnings Snapshot
Yahoo Finance ·
- Minerva Neurosciences reports Q3 results, Phase 3 data due 2H 2027
Investing.com UK ·
- Minerva Neurosciences reports Q3 2026 results, trial on track
StreetInsider ·
Minerva Neurosciences, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | $0 | $0 | $0 |
| Net income | -$293.4M | $1.4M | -$30.0M | -$32.1M |
| Diluted EPS | $-34.67 | $0.19 | $-4.61 | $-6.01 |
| Total assets (year end) | $98.0M | $37.1M | $56.9M | $55.1M |
| Cash and equivalents (year end) | $82.3M | $21.4M | $40.9M | $36.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Minerva Neurosciences, Inc.
- Ticker
- NERV (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Burlington, MA
- Incorporated in
- MA
- Fiscal year end
- December 31
- SEC CIK
- 1598646
Frequently asked questions
What exchange is Minerva Neurosciences, Inc. listed on?
Minerva Neurosciences, Inc. trades on the Nasdaq under the ticker symbol NERV.
What industry is Minerva Neurosciences, Inc. in?
Minerva Neurosciences, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Minerva Neurosciences, Inc. headquartered?
Minerva Neurosciences, Inc.'s business address on file with the SEC is in Burlington, MA.
When does Minerva Neurosciences, Inc.'s fiscal year end?
Minerva Neurosciences, Inc.'s fiscal year ends on December 31.
How much revenue did Minerva Neurosciences, Inc. report?
Minerva Neurosciences, Inc. reported $0 in revenue for calendar year 2024, according to its SEC filings.